PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ian Nason (nason@g.harvard.edu) is a PhD candidate in the Department of Health Care Policy, Harvard Medical School, in Boston, Massachusetts.\', \'Dorit T. Stein is an incoming PhD student in the Department of Global Health and Population, Harvard T. H. Chan School of Public Health,in Boston, Massachusetts.\', \'Richard G. Frank is the Margaret T. Morris Professor of Health Economics in the Department of Health Care Policy, Harvard Medical School.\', \'Murray B. Stein is Distinguished Professor of Psychiatry and Public Health, University of California San Diego, in La Jolla, California.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1377/hlthaff.2021.00028
?:doi
?:hasPublicationType
?:journal
  • Health affairs (Project Hope)
is ?:pmid of
?:pmid
?:pmid
  • 34097524
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all